ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPJ-00662
製品名称
RANKL/TNFSF11/CD254 Protein, Human, Recombinant (E. coli)
タンパク質名
RANKL/TNFSF11/CD254
Species
Human
HOST
E. coli
10μg: -
お問い合わせ

Overview

Synonyms Receptor activator of nuclear factor kappa-B ligand, Receptor activator of nuclear factor κ-B ligand, CD254, tumor necrosis factor ligand superfamily member 11, Osteoclast differentiation factor, TNFSF11, ODF, RANK L, OPGL
Characteristics Loaded Recombinant Human OPG-Fc on Pro A Biosensor, can bind Human RANKL with an affinity constant of 1.83 pM as determined in BLI assay. (Regularly tested)
Endotoxin Level < 0.1 ng/?g (1 EU/?g) as determined by LAL test.
Purity 97%
Description CD254, also known as RANKL, TNFSF11, TRANCE, OPGL and ODF, is a type II membrane protein of the tumor necrosis factor (TNF) superfamily, and affects the immune system and control bone regeneration and remodeling. RANKL is the ligand of nuclear factor (NF)-κB (RANK). When RANKL binds to RANK, it will undergo trimerization and then bind to an adaptor molecule TNF receptor-associated factor 6 (TRAF6). This results in the activation of several downstream signaling cascades, including the NFκB, mitogen-activated protein kinases (MAPK), activating protein 1 (AP-1), and nuclear factor of activated T cells (NFATc1), resulting in the formation of multinucleated bone-resorbing osteoclasts. RANKL is widely expressed in skeletal muscle, thymus, liver, colon, small intestine, adrenal gland, osteoblast, mammary gland epithelial cells, prostate and pancreas.
Reference -
URL https://www.targetmol.com/recombinant-protein/rank_l_protein_human_recombinant

お問い合わせリスト(-)

お問い合わせフォーム